US 11,944,586 B2
Containers with selective dissolved gas content
Freddy Desbrosses, Thuin (BE); Pierpaolo Padula, Venosa (IT); Caroline Roselyne Dupont, Ixelles (BE); Marin Anh-Thuan Demulier, Jumet (BE); and Zouaoui Bourezg, Braine l'Alleud (BE)
Assigned to Baxter International Inc., Deerfield, IL (US); and Baxter Healthcare SA, Glattpark (CH)
Filed by BAXTER INTERNATIONAL INC., Deerfield, IL (US); and BAXTER HEALTHCARE SA, Glattpark (CH)
Filed on May 25, 2021, as Appl. No. 17/330,070.
Prior Publication US 2022/0378655 A1, Dec. 1, 2022
Int. Cl. A61J 1/10 (2006.01); A61K 33/04 (2006.01); A61K 45/06 (2006.01); A61J 1/20 (2006.01)
CPC A61J 1/10 (2013.01) [A61K 33/04 (2013.01); A61K 45/06 (2013.01); A61J 1/2048 (2015.05)] 35 Claims
OG exemplary drawing
 
1. A flexible container of a multi-chamber bag with a selective dissolved gas content for stabilizing at least one compound of a medical product, wherein the multi-chamber bag comprises:
(a) a first chamber containing a carbohydrate formulation;
(b) a second chamber containing an amino acid formulation;
(c) a third chamber containing a lipid formulation; and
(d) a fourth chamber containing a solution comprising the at least one compound requiring the selective dissolved gas for stabilization, the fourth chamber comprising
a headspace of the selective dissolved gas, wherein the solution contained in the fourth chamber comprises at least one selenium compound and wherein the headspace is filled with ambient air, oxygen enriched ambient air, or oxygen.